Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Holtzman

Showing results (271-280 of 293) with videos related to

Pageof 30
Sort By:
British Journal of Haematology|May 5, 2025
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learnedNajla El Jurdi, Noa G Holtzman, Rania Hishmeh, et al.
Bone Marrow Transplantation|August 26, 2021
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host diseaseSencer Goklemez, Leorey N Saligan, Filip Pirsl, et al.
American Journal of Hematology|May 24, 2019
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumabSrilakshmi Bathini, Noa G Holtzman, Rima Koka, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 20, 2026
Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell TherapyLubna Osman-Kardash, Jay Spiegel, Antonio M Jimenez Jimenez, et al.
American Journal of Hematology|January 7, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosisSencer Goklemez, Annie P Im, Liang Cao, et al.
Leukemia & Lymphoma|June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of BaltimoreAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Cureus|July 3, 2026
Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center ExperienceJoseph I Berger, Anthony D Anderson, Octavio V Martinez, et al.
Ophthalmology Science|November 28, 2024
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host DiseaseTaylor McManus, Noa G Holtzman, Aaron Zhao, et al.
Blood Advances|June 5, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapyRick Y Lin, Anthony D Anderson, Yoichiro Natori, et al.
Bone Marrow Transplantation|February 2, 2021
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host diseaseClaire L Ruben, Filip Pirsl, Seth M Steinberg, et al.
Pageof 30

Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|May 5, 2025
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learnedNajla El Jurdi, Noa G Holtzman, Rania Hishmeh, et al.
Bone Marrow Transplantation|August 26, 2021
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host diseaseSencer Goklemez, Leorey N Saligan, Filip Pirsl, et al.
American Journal of Hematology|May 24, 2019
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumabSrilakshmi Bathini, Noa G Holtzman, Rima Koka, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 20, 2026
Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell TherapyLubna Osman-Kardash, Jay Spiegel, Antonio M Jimenez Jimenez, et al.
American Journal of Hematology|January 7, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosisSencer Goklemez, Annie P Im, Liang Cao, et al.
Leukemia & Lymphoma|June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of BaltimoreAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Cureus|July 3, 2026
Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center ExperienceJoseph I Berger, Anthony D Anderson, Octavio V Martinez, et al.
Ophthalmology Science|November 28, 2024
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host DiseaseTaylor McManus, Noa G Holtzman, Aaron Zhao, et al.
Blood Advances|June 5, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapyRick Y Lin, Anthony D Anderson, Yoichiro Natori, et al.
Bone Marrow Transplantation|February 2, 2021
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host diseaseClaire L Ruben, Filip Pirsl, Seth M Steinberg, et al.
Pageof 30